Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

Healthcare Biotechnology
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

CVR Medical Corp > CVR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by wealth100on Oct 10, 2023 8:12am
191 Views
Post# 35676621

RE:RE:RE:RE:CVR

RE:RE:RE:RE:CVRThe restructing deal is in place and was made public on Dec 20, 2022.
Global is/will be out of the picture after a shareholder vote.
The current BOD has made ammends with the TSX and there is a path forward to the FDA/commercialization which is also pulbic knowledge.

Funds are needed to get back up and trading to enable a PP to take place.  Until that hapens it will never move forward.

There have, are and will be investors with positive/forward thinking attitudes investing in this technology not investing in the old stories of the past.  It is time to move on folks.  2019 has past and 2024 is just around the corner.

This tehnology is set up for the present.  Everywhere around the world there is a worker shortage.    CVR has the answer to help millions of people avoid a stroke and stay out in the work force instead of being disabled or even worse, dying.

Its not just up to the board to get this moving again, the Shareholders who want a return on their investment also need to step to the plate...




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities